Earnings ·
Stryker Corporation reported second quarter 2026 operating results, announcing net sales of $6.6 billion, a 9.4%…
SYKStryker Corp
Stryker Corporation reported second quarter 2026 operating results, announcing net sales of $6.6 billion, a 9.4% increase from the prior year period. Organic net sales grew 9.0%, driven by unit volume increases across its MedSurg and Neurotechnology ($3.6 billion) and Orthopaedics ($3.0 billion) segments. Reported diluted earnings per share rose 44.1% to $3.30, while adjusted diluted EPS increased 17.9% to $3.69. The company narrowed its full-year 2026 guidance, now expecting organic net sales growth between 8.3% and 9.3%, with adjusted net earnings per diluted share in the range of $14.95 to $15.10. Stryker operates as a global leader in medical technologies, providing innovative products and services in MedSurg, Neurotechnology, and Orthopaedics.